Yicheng Zhang

8PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 22, 2026
Long-term follow-up of third generation anti-CD30 CAR T-cell therapy in relapsed/refractory CD30+ lymphomas: a single-arm, multicentre, phase 1-2 trial.

|Jun 24, 2026
Febrile neutropenia adversely affects chemomobilization outcomes in patients with multiple myeloma and increases risk for post-transplant infection in those with lymphoma: real-world multicenter data.

|Jan 15, 2026
Chimeric antigen receptor T‑cell therapy in chronic viral infections: a review.

Qiyang Han, Xiaoying Zhang, Liting Chen

|Dec 25, 2025
The roles and clinical applications of mesenchymal stem cells and their exosomes in hematologic diseases.

Mengxue Deng, Xiaoying Zhang, Yicheng Zhang

|Nov 07, 2025
Immune-Related Adverse Events in a Patient With Burkitt's Lymphoma During PD-1 Immune Consolidation Therapy: A Case Report.

Qi Zhang, Fankai Meng, Yang Cao

|Oct 24, 2025
Long-term Therapy Outcomes of CD19/22 CAR T Cell Alone or with Autologous Stem Cell Transplantation for Relapsed/Refractory DLBCL.

Xiaoying Zhang, Jue Wang, Na Wang

Pageof 2

Frequent Collaborators

4 joint publications

Jia Wei

2 joint publications

Yi Xiao

2 joint publications

Xiaojian Zhu

1 joint publications

Xiangke Xin